Studies on the pathogenesis of drug-resistant herpes simplex virus infections in humans and development of a novel and rapid sensitivity assay system
| Project/Area Number |
21591402
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | National Institute of Infectious Diseases |
|---|
Principal Investigator |
SAIJO Masayuki 国立感染症研究所, ウイルス第一部, 部長 (50300926)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | ウイルス感染症 / 薬剤耐性 / 免疫不全 / 単純ヘルペス / 単純ヘルペスウイルス / アシクロビル / ガンシクロビル / 薬剤感受性 / 迅速診断 / 臓器移植 / 単純ヘルペイウイルス |
|---|
| Research Abstract |
A life-long HSV-1 infections in a child with a congenital immunodeficiency syndrome, Wiskott-Aldrich syndrome(WAS), was closely observed virologically and clinically. The observation based on the virological analyses demonstrated that acyclovir(ACV), anti-HSV-1 drug-resistant HSV-1 infections emerged during the course of his life. Furthermore, it was revealed that virus thymidine kinase(vTK)-deficient and highly ACV-resistant HSV-1 could reactivate in humans, despite vTK-deficient HSV-1 was reported to be able to establish latency in neuronal ganglia, but not reactivate from latency. The vTK-deficient HSV-1 in the patient was revealed to reactivate from latency by the assistance of the vTK-positive and ACV-sensitive HSV-1 when it reactivated. An efficacious rapid antiviral sensitivity assay system was developed. The sensitivity of HSV-1 could be determined by measuring the inhibitory effect of ACV and other vTK-associated drugs on the replication of vTK-deficient HSV-1 in 293T cells expressed with recombinant vTK of the interest virus by transfection of the cells with mammalian cell expression vectors. The interest virus would be determined to be ACV-resistant if the inhibitory effect was significantly less than that in the cells expressed with wild? type vTK. The system can be applied not only to HSV-1, but also to varicella zoster virus.
|
Report
(4 results)
Research Products
(17 results)
-
-
-
[Journal Article] Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay2011
Author(s)
Shiota T, Wang L, Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.
-
Journal Title
Antiviral Research
Volume: 91
Pages: 142-149
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Presentation] Shedding of herpes simplex virus type 1 (HSV-1) and emergence of drug-resist ant HSV-1 in patients with hematopoietic stem cell transplantation in Japan2011
Author(s)
Wang, L., Tsuji, M., Taniguchi, S., Nishimura, H., Ito-(Takayama), M., Yamaguchi-(Kinoshita), H., Saijo, M.
Organizer
XV International Congress of Virology, Sapporo, Japan
Place of Presentation
札幌
Related Report
-
-
-
-
-
-
-
